Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 94

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 94
---
.5% of the amount or value of the consideration given or, in
certain circumstances, the value of the shares.

There is an exception from the 1.5% charge
on the transfer to, or to a nominee, a clearance service where the clearance service has made and maintained an election under section
97A(1) of the Finance Act 1986, which has been approved by HMRC. If such an election were made by a clearance service, SDRT at the rate
of 0.5% of the amount or value of the consideration payable for the transfer would arise on any transfer of an ordinary share into such
a clearance service and on subsequent agreements to transfer such share within such clearance service. It is our understanding that DTC
has not to date made an election under section 97A(1) of the Finance Act of 1986.

Any liability for stamp duty or SDRT in respect of a transfer into a clearance service or depositary receipt system, or in respect of a transfer within such a service, which does arise, will strictly be accountable to HMRC by the clearance service or depositary receipt system operator or their nominee, as the case may be, but will, in practice, be payable by the participants in the clearance service or depositary receipt system.

Certain United States Taxation Matters

The following discussion describes
the material United States federal income tax considerations to U.S. Holders (as defined below) under present law of the purchase, ownership
and disposition of the Depositary Shares and the warrants. This discussion is based on the United States Internal Revenue Code of 1986,
as amended, or the Code, for purposes of this discussion, in effect as of the date of this prospectus and on United States Treasury Regulations
in effect or, in some cases, proposed, as of the date of this prospectus, as well as judicial and administrative interpretations thereof
available on or before such date. All of the foregoing authorities are subject to change, which change could apply retroactively and could
affect the tax consequences described below.

| 64 |

This discussion applies only
to U.S. Holders that hold the Depositary Shares and the warrants as capital assets for United States federal income tax purposes. It does
not purport to be a comprehensive description of all tax considerations that may be relevant to a decision to purchase the Depositary
Shares and the warrants by any particular investor. In particular, this discussion does not address tax considerations applicable to a